Welcome to today's Medical News Today News Alert containing today's medical news headlines for your chosen categories. You will only receive these alerts when new news is available for your chosen categories.
To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
----------------------------------------------
** BREAST CANCER News **
Cytokinetics Announces Clinical And Preclinical Data Regarding Ispinesib For Breast Cancer Treatment
http://www.medicalnewstoday.com/articles/132906.php
Cytokinetics, Incorporated (NASDAQ: CYTK) announced today that two posters, one summarizing interim Phase I clinical trial data evaluating ispinesib in the treatment of breast cancer and another containing preclinical data for ispinesib, were presented at the 31st Annual San Antonio Breast Cancer Symposium (SABCS) held on December 10-14, 2008.
Agendia's MammaPrint(R) Predicts Response To Neoadjuvant Chemotherapy In Breast Cancer
http://www.medicalnewstoday.com/articles/132903.php
Agendia, a world leader in molecular cancer diagnostics, today announced MammaPrint(R)'s ability to predict response to neoadjuvant chemotherapy in breast cancer. Â Â Â Dr. Laura van 't Veer, from the Netherlands Cancer Institute, presented the data at the 2008 San Antonio Breast Cancer Symposium (SABCS) during the session Molecular profiling for guiding therapeutic decisions.
----------------------------------------------
** CANCER / ONCOLOGY News **
Cytokinetics Announces Clinical And Preclinical Data Regarding Ispinesib For Breast Cancer Treatment
http://www.medicalnewstoday.com/articles/132906.php
Cytokinetics, Incorporated (NASDAQ: CYTK) announced today that two posters, one summarizing interim Phase I clinical trial data evaluating ispinesib in the treatment of breast cancer and another containing preclinical data for ispinesib, were presented at the 31st Annual San Antonio Breast Cancer Symposium (SABCS) held on December 10-14, 2008.
World's First Low Radiocarbon Food May Reduce Risks Of Cancer And Birth Defects
http://www.medicalnewstoday.com/articles/132904.php
An Ohio-based company has successfully grown the first Low Radiocarb(TM) food, in this case soybeans, with significantly lower levels of harmful radioactive carbon-14 than normally found in food.
Agendia's MammaPrint(R) Predicts Response To Neoadjuvant Chemotherapy In Breast Cancer
http://www.medicalnewstoday.com/articles/132903.php
Agendia, a world leader in molecular cancer diagnostics, today announced MammaPrint(R)'s ability to predict response to neoadjuvant chemotherapy in breast cancer. Â Â Â Dr. Laura van 't Veer, from the Netherlands Cancer Institute, presented the data at the 2008 San Antonio Breast Cancer Symposium (SABCS) during the session Molecular profiling for guiding therapeutic decisions.
Removal Of Pelvic Lymph Nodes Or Radiotherapy Cannot Be Recommended As Routine Treatments In Women With Early Endometrial Cancer (Astec Study)
http://www.medicalnewstoday.com/articles/132802.php
Two Articles published Online first and in an upcoming edition of <i>The Lancet</i> show that two common adjuvant treatments for women with early endometrial cancer - removing the pelvic lymph nodes or external beam radiotherapy - should not be part of routine care.
----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **
No news for this category today.
----------------------------------------------
** COLORECTAL CANCER News **
No news for this category today.
----------------------------------------------
** LUNG CANCER News **
No news for this category today.
----------------------------------------------
** LYMPHOMA / LEUKEMIA News **
No news for this category today.
----------------------------------------------
** PROSTATE / PROSTATE CANCER News **
Recent London Improvements In Curative Radiation Therapy For Relevant Early Prostate Cancer
http://www.medicalnewstoday.com/articles/132934.php
UroToday.com - The most effective form of treatment for localized prostate cancer remains a matter of great debate. There are no randomized controlled trials comparing radiotherapy with prostatectomy.
Evaluation Of T2-Weighted And Dynamic Contrast-Enhanced MRI In Localizing Prostate Cancer Before Repeat Biopsy Radiology
http://www.medicalnewstoday.com/articles/132919.php
UroToday.com - Even with extended biopsy protocols, a negative set of biopsies does not rule out the presence of cancer. Among the patients with negative 10- to 12-core biopsy schemes, 17-21.
-------------------------------------------------------------
You are receiving this news alert e-mail because you subscribed via an online form on our web site. If you wish to unsubscribe, please visit
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
No comments:
Post a Comment